Icon (ICLR) Receivables (2009 - 2026)
Icon's (ICLR) quarterly Receivables came in at $2.5 billion in Q2 2026, down 3.79% year-over-year from $2.6 billion in Q2 2025, and down 1.93% quarter-over-quarter from $2.6 billion in Q1 2026.
Analysis
Icon (ICLR) Receivables (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Receivables for 18 consecutive years, with $2.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Receivables fell 3.79% year-over-year to $2.5 billion in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 3.79% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 5.69% from the prior year.
- Receivables was $2.5 billion for Q2 2026 at Icon, down from $2.6 billion in the prior quarter.
- Over five years, Receivables peaked at $3.3 billion in Q1 2024 and troughed at $1.8 billion in Q4 2023.
- A 5-year average of $2.6 billion and a median of $2.6 billion in 2025 frame the typical range for Receivables.
- Across the five-year window, Receivables jumped 90.19% in 2022 and slumped 34.38% in 2023, its largest moves.
- Over 5 years, Receivables stood at $2.7 billion in 2022, then tumbled by 34.38% to $1.8 billion in 2023, then surged by 37.88% to $2.4 billion in 2024, then grew by 5.69% to $2.6 billion in 2025, then decreased by 2.28% to $2.5 billion in 2026.
- The last three Receivables figures came in at $2.5 billion (Q2 2026), $2.6 billion (Q1 2026), and $2.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 5.16 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 463.06 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.51 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 720.47 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 654.40 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 150.69 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 20.41 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 22.87 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.06 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 29,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.51 Bn |
| Mar 31, 2026 | 2.56 Bn |
| Dec 31, 2025 | 2.57 Bn |
| Sep 30, 2025 | 2.65 Bn |
| Jun 30, 2025 | 2.61 Bn |
| Mar 31, 2025 | 2.58 Bn |
| Dec 31, 2024 | 2.43 Bn |
| Sep 30, 2024 | 2.76 Bn |
| Jun 30, 2024 | 2.80 Bn |
| Mar 31, 2024 | 3.28 Bn |
| Dec 31, 2023 | 1.76 Bn |
| Sep 30, 2023 | 2.79 Bn |
| Jun 30, 2023 | 2.74 Bn |
| Mar 31, 2023 | 2.78 Bn |
| Dec 31, 2022 | 2.69 Bn |
| Sep 30, 2022 | 2.33 Bn |
| Jun 30, 2022 | 2.07 Bn |
| Mar 31, 2022 | 2.05 Bn |
| Dec 31, 2021 | 1.97 Bn |
| Sep 30, 2021 | 1.89 Bn |